|
HSPA1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.744640E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.212790E-01 |
| Normal-vs-Stage2 |
1.381730E-02 |
| Normal-vs-Stage3 |
6.603000E-01 |
| Normal-vs-Stage4 |
1.497570E-01 |
| Stage1-vs-Stage2 |
1.182770E-01 |
| Stage1-vs-Stage3 |
5.713400E-01 |
| Stage1-vs-Stage4 |
7.195000E-01 |
| Stage2-vs-Stage3 |
2.043200E-01 |
| Stage2-vs-Stage4 |
5.832800E-01 |
| Stage3-vs-Stage4 |
4.363800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.303400E-01 |
| Normal-vs-AfricanAmerican |
6.842500E-03 |
| Normal-vs-Asian |
7.727000E-01 |
| Caucasian-vs-AfricanAmerican |
2.755900E-02 |
| Caucasian-vs-Asian |
3.997800E-01 |
| AfricanAmerican-vs-Asian |
3.333400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.462600E-01 |
| Normal-vs-Female |
4.782000E-03 |
| Male-vs-Female |
1.730170E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.431800E-04 |
| Normal-vs-Extreme_Weight |
8.198000E-01 |
| Normal-vs-Obese |
1.797990E-02 |
| Normal-vs-Extreme_Obese |
6.898100E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.617300E-04 |
| Normal_Weight-vs-Obese |
1.120210E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.707800E-01 |
| Extreme_Weight-vs-Obese |
1.744150E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.895700E-02 |
| Obese-vs-Extreme_Obese |
6.975600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.362390E-01 |
| Normal-vs-Age(41-60Yrs) |
8.518400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.107600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.002420E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.726000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.697000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.266800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.399200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.082200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.696200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.213400E-01 |
| Normal-VS-Type2 PRCC |
3.034000E-02 |
| Normal-VS-KIRP CIMP |
4.16140000000231E-05 |
| Normal-VS-Unclassified PRCC |
5.718400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.310300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.21570000003002E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
1.506370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.029900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.284000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.802300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.634300E-02 |
| Normal-vs-N1 |
4.815400E-01 |
| Normal-vs-N2 |
7.678400E-02 |
| N0-vs-N1 |
5.588600E-01 |
| N0-vs-N2 |
4.058400E-01 |
| N1-vs-N2 |
3.747400E-01 |
|
|
